NemethE.F., SteffeyM.E., HammerlandL.G.. Calcicimetics with potent and selective activity on the parathyroid calcium receptor.Proc Natl Acad Sci USA1998; 95: 4040–5.
2.
KawataT., ImanishiY., KobayashiK.. Direct in vitro evidence of the suppressive effect of cinacalcet HCL on parathyroid hormone secretion in human parathyroid cells withpathologically reduced calcium-sensing receptor levels.J Bone Miner Metab2006; 24: 300–06.
3.
BlockG.A., MartinK.J., de FranciscoA.L., TurnerS.A., AvramM.M., SuranyiM.G.. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis.N Engl J Med2004; 350(15): 1516–25.
4.
LindbergJ.S., CulletonB., WongG., BorahM.F., ClarkR.V., ShapiroW.B.. Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study.J Am Soc Nephrol2005; 16(3): 800–7.
5.
BilezikianJ.P., PottsJ.T., FuleihanG.. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century.J Clin Endocrinol Metab2002; 87: 5353–61.
6.
SelbyP.L., PeacockM.Ethinyl estradiol and norethindrone in the treatment of primary hyperparathyroidism in postmenopausal womem.N Engl J Med1996; 314: 1481–85.
7.
ChowC.C., ChanW.B., LiJ.K.. Oral alendronate increases bone mineral density in postmenopausal women with primary hyperparathyroidism.J Clin Endocrinol Metab2003; 88: 581–87.
8.
Orr-WalkerB.J., EvansM.C., ClearwaterJ.M., HorneA., GreyA.B., ReidI.R.Effects of hormone replacement therapy on bone mineral density in postmenopausal women with primary hyperparathyroidism: four-year follow-up and comparison with healthy postmenopausal women.Arch Intern Med2000; 160(14): 2161–6.
9.
HassaniS., BraunsteinG.D., SebelM.J.. Alendronate therapy of primary hyperparathyroidism.Endocrinologist2001; 11: 459–64.
10.
VestergaardP.Current pharmacological option for the management of primary hyperparathyroidism.Drugs2006; 66: 2189–211.
11.
PeacockM., BilezikianJ.P., KlassenP.S., GuoM.D., TurnerS.A., ShobackD.Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism.J Clin Endocrinol Metab2005; 90(1Il calciomimetico nell'iperparatiroidismo primitivo e se): 135–41.
12.
Sajid-CrockettS., SingerF.R., HershmanJ.M.Cinacalcet for the treatment of primary hyperparathyroidism.Metabolism2008; 57(4): 517–21.
13.
IglesiasP., AisG., GonzálezA., TajadaP., Garc'a ArévaloC., Fernández PardoE., D'ezJ.J.Acute and one-year effects of cinacalcet in patients with persistent primary hyperparathyroidism after unsuccessful parathyroidectomy.Am J Med Sci2008; 335(2): 111–4.
14.
RiccardiD., HallA.E., ChattopadhyayN.. Localization of the extracellular CA2+/polyvalent cation-sensing protein in rat kidney.Am J Physiol1998; 274: F611–22.
